DS
OCEA

David Shaw’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

David Shaw’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-524,700
Closed -$5.46M – 4955
2022
Q4 		$5.46M Hold
524,700
– – 0.01% 2016
2022
Q3 		$5.35M Hold
524,700
– – 0.01% 2014
2022
Q2 		$5.33M Buy
524,700
+74,700
+17% +$755K 0.01% 2044
2022
Q1 		$4.54M Hold
450,000
– – ﹤0.01% 2425
2021
Q4 		$4.5M Buy
+450,000
New +$4.49M ﹤0.01% 2494

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
QL
Quarry LP New York $1.2B AUM 47.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

David Shaw's OCEA Position: Q1 2023 in Review

David Shaw sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2023, closing a stake of 524,700 shares — an estimated $5.46M sold.

David Shaw first reported a position in OCEA in Q4 2021 and held it in 5 quarters. The position peaked at $5.46M in Q4 2022. 17 funds tracked by Wall St. Rank hold OCEA as of Q1 2023.

  • David Shaw reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • David Shaw sold 524,700 Ocean Biomedical, Inc. Common Stock shares in Q1 2023, an estimated $5.46M.
  • David Shaw first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • David Shaw's Ocean Biomedical, Inc. Common Stock position peaked at $5.46M in Q4 2022.
  • 17 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.